Video: Pfizer and Allergan scrap $160-billion deal

U.S. drug maker Pfizer has agreed to terminate its $160 billion agreement to acquire Botox maker Allergan Plc, in a major victory to U.S. President Barack Obama's drive to stop tax-dodging corporate mergers. Hayley Platt reports